Edgewise Therapeutics Stock Predictions

Not Meta. Not Google. AI 2.0 Is Here, And It's Still Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Sell

EWTX
Edgewise Therapeutics

Last Price:

$14.20

Seasonality Move:

-4.9%

7 Day Trial

ALL ACCESS PASS

$ 7

This $60K Foldable Home Is Shaking Up Real Estate

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Edgewise Therapeutics Stock Forecast

Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 8.6% based on the past 4 years of stock performance.
Edgewise Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Edgewise Therapeutics Stock Undervalued?

The current Edgewise Therapeutics [EWTX] share price is $14.21. The Score for EWTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
EWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Edgewise Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 8.6% based on the past 4 years of stock performance.

Edgewise Therapeutics Stock Rating

Sell

Edgewise Therapeutics (EWTX) is a Sell

Is Edgewise Therapeutics overpriced?

Edgewise Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Edgewise Therapeutics Stock Price History

Is EWTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

edgewisetx.com

52-Week Data

52-Week High:

38.12

52-Week Low:

10.60

Prediction Charts

Market Cap:

1.5B

Price in USD:

14.21

Volume:

Beta:

0.36

Technical Analysis

SMA50:

16.66

SMA100:

21.79

SMA200:

24.38

52-Wk Change:

-17.91%

Stock Predictions

Is Edgewise Therapeutics stock public?

Yes, Edgewise Therapeutics is a publicly traded company.
What is the Edgewise Therapeutics stock quote today?

The Edgewise Therapeutics stock price is 14.21 USD today.
How to buy Edgewise Therapeutics stock online?

You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-6	16.36	14.38	16.53	14.08
May-7	14.42	14.52	14.95	14.22
May-8	14.51	14.70	14.99	13.82
May-9	14.95	14.58	15.55	14.51
May-12	15.35	14.82	15.82	14.68
May-13	14.86	14.89	14.99	14.37
May-14	14.94	14.55	15.11	13.91
May-15	14.57	14.45	14.64	14.07
May-16	14.48	14.78	14.99	14.26
May-19	14.45	14.79	14.92	14.05
May-20	14.80	14.87	15.34	14.68
May-21	14.70	14.59	14.84	14.13
May-22	14.54	14.02	14.60	13.98
May-23	14.05	14.21	14.31	13.63

Edgewise Therapeutics Earnings

Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Edgewise Therapeutics Forecast Revenue Growth

Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.22 per share.

* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.